These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23588816)

  • 1. Osteoporosis and HIV.
    O'Connor MB
    Ir J Med Sci; 2013 Dec; 182(4):747-8. PubMed ID: 23588816
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.
    Rothman MS; Bessesen MT
    Curr Osteoporos Rep; 2012 Dec; 10(4):270-7. PubMed ID: 23100110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
    Biver E; Calmy A; Aubry-Rozier B; Birkhäuser M; Bischoff-Ferrari HA; Ferrari S; Frey D; Kressig RW; Lamy O; Lippuner K; Suhm N; Meier C
    Osteoporos Int; 2019 May; 30(5):1125-1135. PubMed ID: 30603840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options for low bone mineral density in HIV-infected subjects.
    Cotter AG; Mallon PW
    Curr HIV/AIDS Rep; 2012 Jun; 9(2):148-59. PubMed ID: 22528765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and bone disease: implications for an aging population.
    Cotter AG; Mallon PW
    Sex Health; 2011 Dec; 8(4):493-501. PubMed ID: 22127034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir-associated severe bone pain: I cannot walk!
    Jhaveri MA; Mawad HW; Thornton AC; Mullen NW; Greenberg RN
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):328-34. PubMed ID: 20923957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone changes and fracture risk in individuals infected with HIV.
    Warriner AH; Mugavero MJ
    Curr Rheumatol Rep; 2010 Jun; 12(3):163-9. PubMed ID: 20425517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the management of osteoporosis and vitamin D deficiency in HIV infection.
    Brown TT
    Top Antivir Med; 2013; 21(3):115-8. PubMed ID: 23981599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies.
    Walker Harris V; Brown TT
    J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S391-8. PubMed ID: 22577213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone aging and frailty syndrome after 10 years of ARV treatment in Senegal].
    Cournil A; Eymard-Duvernay S; Diouf A;
    Bull Soc Pathol Exot; 2014 Oct; 107(4):238-40. PubMed ID: 24615435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone health in HIV infection.
    Pollock E; Klotsas AE; Compston J; Gkrania-Klotsas E
    Br Med Bull; 2009; 92():123-33. PubMed ID: 19875393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of bone mineral density in HIV-infected patients.
    Negredo E; Bonjoch A; Clotet B
    Expert Opin Pharmacother; 2016; 17(6):845-52. PubMed ID: 26809940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.
    Tomazic J; Ul K; Volcansek G; Gorensek S; Pfeifer M; Karner P; Prezelj J; Vidmar G; Vidmar L
    Wien Klin Wochenschr; 2007; 119(21-22):639-46. PubMed ID: 18043884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients.
    Cervero M; Torres R; Agud JL; Alcázar V; Jusdado JJ; García-Lacalle C; Moreno S
    PLoS One; 2018; 13(4):e0196201. PubMed ID: 29709013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
    McGinty T; Mallon P
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient guide to osteoporosis in men.
    Adler RA; Finkelstein J
    J Clin Endocrinol Metab; 2012 Jun; 97(6):39A-40A. PubMed ID: 22675070
    [No Abstract]   [Full Text] [Related]  

  • 20. Complications of Treatment in Youth with HIV.
    Eckard AR; Fowler SL; Haston JC; Dixon TC
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):226-33. PubMed ID: 27234970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.